Topic: Atomoxetine

During news segments about the Adderall shortage, medical experts have begun suggesting Strattera as a non-stimulant alternative. Strattera, manufactured by Eli Lilly, contains atomoxetine and works as a norepinephrine reuptake inhibitor. The hosts argue that the media coverage resembles a long-form commercial for Eli Lilly, aimed at transitioning patients from generic stimulants to branded metabolic-altering drugs.